New pill aims to help control weight in early trial
NCT ID NCT07166081
Summary
This early-stage study is testing a new oral medication called BGM0504 for weight management in non-diabetic adults who are overweight or obese. Researchers will give 80 participants either the active tablet or a placebo daily to assess safety, how the body processes the drug, and its effects on body weight. The goal is to gather initial data on whether this approach could help control weight with fewer side effects than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pharmaron CPC, Inc
RECRUITINGBaltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.